Publications

5674 Results

A randomized trial comparing 14-day triple, 10-day sequential, and 5-day concomitant therapy to eradicate Helicobacter pylori in seven Latin American populations

Authors
C Ferreccio;G Anderson;D Morgan;J Torres;LE Bravo;R Dominguez;R Herrero;M Meza-Montenegro;R Pena;E Salazar-Martinez;W Chey;M Valdivieso;J Crowley;G Goodman;ER Greenberg;LH Baker
Journal / Conference
Digestive Disease Week 2011 meeting, oral presentation
Year
2011
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0701

SWOG cooperative group biorepository resource: access for scientific research studies

Authors
C Hoban;W Franklin;K Kopecky;L Baker
Journal / Conference
Clinical Cancer Research 17(16):5239-5246;
Year
2011
Research Committee(s)
Molecular Epidemiology and Multiple sites
PMID
PMID21555374

A secure website for participant submission of follow-up data

Authors
J Hartline;A Smith;K Anderson
Journal / Conference
Society for Clinical Trials 2011 Annual Meeting, oral;
Year
2011
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221) [PMID21766209; PMC33532924]

Authors
L Sucheston;H Zhao;S Yao;G Zirpoli;S Liu;W Barlow;HCF Moore;G Budd;D Hershman;W Davis;G Ciupak;J Stewart;C Isaacs;T Hobday;M Salim;G Hortobagyi;J Gralow;R Livingston;K Albain;D Hayes;C Ambrosone
Journal / Conference
Breast Cancer Research and Treatment, 130(3):993-1002;
Year
2011
Research Committee(s)
Breast
Study Number(s)
S0221

Study transition from local in-person follow-up to centralized follow-up by mail

Authors
K Anderson;J Hartline;J Harris-Talley
Journal / Conference
American Society of Preventive Oncology Annual Meeting 2011, poster presentation
Year
2011
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

The consent process for transitioning a large trial to centralized follow-up

Authors
M Yee;JA Hartline;K Anderson
Journal / Conference
American Society of Preventive Oncology Annual Meeting 2011, poster presentation
Year
2011
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Serum phospholipid fatty acids and prostate cancer risk: results from the Prostate Cancer Prevention Trial. PMID21518693; PMC3145396

Authors
TM Brasky;E White;M Neuhouser;IM Thompson;X Song;C Till;A Kristal
Journal / Conference
American Journal of Epidemiology 173(12):1429-1439;
Year
2011
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

S0356: A phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma [PMID22025151;PMC3236655]

Authors
LP Leichman;B Goldman;C Thomas;K Billingsley;C Corless;J Benedetti;HJ Lenz;S Iqbal;P Gold;CD Blanke
Journal / Conference
Journal of Clinical Oncology, 29(34):4555-4560; 2011 Oct 24 [Epub ahead of print];
Year
2011
Research Committee(s)
Gastrointestinal
Study Number(s)
S0356

Colorectal chemoprevention pilot study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions [PMID21782524;NIHMS326411]

Authors
D Chu;M Hussey;D Alberts;F Meyskens;C Fenoglio-Preiser;S Rivkin;G Mills;J Giguere;C Blanke;G Goodman
Journal / Conference
Clinical Colorectal Cancer 10(4):310-316;
Year
2011
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9041

A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: SWOG study S0605

Authors
M Sekeres;H Gundacker;J Lancet;A Advani;S Petersdorf;J Liesveld;D Mulford;T Norwood;C Willman;A List;F Appelbaum
Journal / Conference
Blood 118(3):523-528;
Year
2011
Research Committee(s)
Leukemia
Study Number(s)
S0605